Stevanato Group Spa

NYSE:STVN 3:59:59 PM EDT

17.04

-0.31 (-1.79%)

Market Cap (Intraday)	4.35B
Current PE	35.76
Forward PE	33.41
2yr Forward PE	32.15

See more stats

Estimates Current Quarter

Revenue	$243.56 Million
Adjusted EPS	$0.13

See more estimates

10-Day MA	$17.37
50-Day MA	$17.16
200-Day MA	$17.37

See more pivots

Stevanato Group Spa Stock, NYSE:STVN

Via Molinella 17, Piombino Dese, Padova 35017

Italy

Phone: +39.049.9318111

Number of Employees:

http://www.stevanatogroup.com

Description

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.